Pacific Biosciences Of Stock Analysis

Pacific Stock Analysis Notes

About 78.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.76. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pacific Biosciences has Price/Earnings (P/E) ratio of 197.88. The entity recorded a loss per share of 1.59. The firm had not issued any dividends in recent years. Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California. Pacific Biosciences operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 728 people. To find out more about Pacific Biosciences of contact Christian MBA at 650 521 8000 or learn more at https://www.pacb.com.

Pacific Biosciences Investment Alerts

Pacific Biosciences Upcoming and Recent Events

Pacific Largest EPS Surprises

View All Earnings Estimates

Pacific Biosciences Thematic Classifications

Pacific Stock Institutional Investors

Note, although Pacific Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pacific Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 396.14 M.

Pacific Profitablity

The company has Profit Margin (PM) of (2.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.28) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.28.

Management Efficiency

Pacific Biosciences has return on total asset (ROA) of (0.1209) % which means that it has lost $0.1209 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.513) %, meaning that it created substantial loss on money invested by shareholders. Pacific Biosciences' management efficiency ratios could be used to measure how well Pacific Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of March 25, 2025, Return On Tangible Assets is expected to decline to -0.59. In addition to that, Return On Capital Employed is expected to decline to -0.31. At present, Pacific Biosciences' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 803 M, whereas Other Assets are forecasted to decline to 1.09.

Technical Drivers

As of the 25th of March, Pacific Biosciences holds the Coefficient Of Variation of (1,329), risk adjusted performance of (0.06), and Variance of 35.7. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pacific Biosciences, as well as the relationship between them.

Pacific Biosciences Price Movement Analysis

Pacific Biosciences Insider Trading Activities

Pacific Biosciences Outstanding Bonds

Pacific Biosciences Predictive Daily Indicators

Pacific Biosciences Forecast Models

Pacific Biosciences' time-series forecasting models are one of many Pacific Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pacific Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pacific Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pacific shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pacific Biosciences. By using and applying Pacific Stock analysis, traders can create a robust methodology for identifying Pacific entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pacific analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pacific analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pacific Biosciences of stock analysis indicators help investors evaluate how Pacific Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pacific Biosciences shares will generate the highest return on investment. By understating and applying Pacific Biosciences stock analysis, traders can identify Pacific Biosciences position entry and exit signals to maximize returns.

When running Pacific Biosciences' price analysis, check to measure Pacific Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacific Biosciences is operating at the current time. Most of Pacific Biosciences' value examination focuses on studying past and present price action to predict the probability of Pacific Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacific Biosciences' price. Additionally, you may evaluate how the addition of Pacific Biosciences to your portfolios can decrease your overall portfolio volatility.